These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Role of ASXL1 in hematopoiesis and myeloid diseases. Gao X; You X; Droin N; Banaszak LG; Churpek J; Padron E; Geissler K; Solary E; Patnaik MM; Zhang J Exp Hematol; 2022 Nov; 115():14-19. PubMed ID: 36183966 [TBL] [Abstract][Full Text] [Related]
10. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia. Bera R; Chiu MC; Huang YJ; Lin TH; Kuo MC; Shih LY J Hematol Oncol; 2019 Oct; 12(1):104. PubMed ID: 31640815 [TBL] [Abstract][Full Text] [Related]
11. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure. Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB; J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413 [TBL] [Abstract][Full Text] [Related]
12. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Köhnke T; Nuno KA; Alder CC; Gars EJ; Phan P; Fan AC; Majeti R Blood Cancer Discov; 2024 May; 5(3):202-223. PubMed ID: 38359087 [TBL] [Abstract][Full Text] [Related]
13. The role of clonal progression leading to the development of therapy-related myeloid neoplasms. Guarnera L; Pascale MR; Hajrullaj H; Cristiano A; Mallegni F; Onorato A; Voso MT; Fabiani E Ann Hematol; 2024 Sep; 103(9):3507-3517. PubMed ID: 39031199 [TBL] [Abstract][Full Text] [Related]
15. The role of ASXL1 in hematopoiesis and myeloid malignancies. Asada S; Fujino T; Goyama S; Kitamura T Cell Mol Life Sci; 2019 Jul; 76(13):2511-2523. PubMed ID: 30927018 [TBL] [Abstract][Full Text] [Related]
16. The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model. Hsu YC; Chiu YC; Lin CC; Kuo YY; Hou HA; Tzeng YS; Kao CJ; Chuang PH; Tseng MH; Hsiao TH; Chou WC; Tien HF J Hematol Oncol; 2017 Jul; 10(1):139. PubMed ID: 28697759 [TBL] [Abstract][Full Text] [Related]
17. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk. Haring B; Wissel S; Manson JE Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494 [TBL] [Abstract][Full Text] [Related]
18. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. Abdel-Wahab O; Gao J; Adli M; Dey A; Trimarchi T; Chung YR; Kuscu C; Hricik T; Ndiaye-Lobry D; Lafave LM; Koche R; Shih AH; Guryanova OA; Kim E; Li S; Pandey S; Shin JY; Telis L; Liu J; Bhatt PK; Monette S; Zhao X; Mason CE; Park CY; Bernstein BE; Aifantis I; Levine RL J Exp Med; 2013 Nov; 210(12):2641-59. PubMed ID: 24218140 [TBL] [Abstract][Full Text] [Related]
19. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160 [TBL] [Abstract][Full Text] [Related]
20. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors. Reed SC; Croessmann S; Park BH Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]